16/04/2014 12:12:18 Free Membership Login

   

Alexion Pharmaceuticals, Inc.

Visual Financials
Company Name: Alexion Pharmaceuticals, Inc.
Ticker Symbol: ALXN
WWW Address: http://www.alexionpharm.com
CEO: Leonard Bell
No. of Employees: 1,373
Common Issue Type: CS
Business Description:Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 147.23 Up 1.81 147.22 147.44 147.17 147.99 136.37 549606
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 28,868.0 196.1 0.56 1.78 0.00 74.6 0.0 185.43 - 87.01
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close138.61$
PE Ratio - LTM74.6
Market Capitalisation28,868.0mil
Latest Shares Outstanding196.1mil
Earnings pS (EPS)1.78$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee826,012$
Effective Tax Rate35.9%
Float171.5mil
Float as % of Shares Outstanding88.0%
Foreign Sales734mil
Domestic Sales400mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS1.97$
Book-Value pS12.00$
Tangible Book-Value pS0.00$
Cash Flow pS0.00$
Free Cash Flow pS0.00$
KEY FIGURES (LTM): Price info
Price/Book Ratio10.96
Price/Tangible Book Ratio0.00
Price/Cash Flow66.6
Price/Free Cash Flow71.9
P/E as % of Industry Group241.0%
P/E as % of Sector Segment48.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----3.9-32,118,2723,822,625
4 Weeks181.74136.37180.94-21.5-202,316,70748,650,865
13 Weeks185.43126.76130.558.771,899,448123,464,184
26 Weeks185.43100.89108.2431.2231,492,839188,097,798
52 Weeks185.4387.0196.2047.6311,432,937362,533,131
YTD185.43126.76-6.461,810,912130,385,725
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
144.05146.20165.26137.96130.090.560.69
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue50.3495.836.80
Income0.000.05.71
Dividend0.000.00.00
Capital Spending42.43NA150.77
R&D28.58NA38.53
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %38.538.544.8
Earnings %81.081.045.4
EPS %78.378.340.7
EPS $0.180.180.37
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio43.45
Current Ratio4.2
Quick Ratio (Acid Test)3.6
Liquidity Ratio (Cash)2.75
Receivables Turnover4.2
Average Collection Period86
Working Capital/Equity57.6
Working Capital pS5.83
Cash-Flow pS1.43
Free Cash-Flow pS-1.11
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio25.68
Financial Leverage Ratio (Assets/Equity)1.3
Debt Ratio24.6
Total Debt/Equity (Gearing Ratio)0.08
LT Debt/Equity0.05
LT Debt/Capital Invested13.6
LT Debt/Total Liabilities15.7
Interest Cover54.7
Interest/Capital Invested0.33
 
VALUATION RATIOS
MULTIPLES
PQ Ratio41.00
Tobin's Q Ratio9.88
Current P/E Ratio - LTM74.60
Enterprise Value (EV)/EBITDA60.10
Enterprise Value (EV)/Free Cash Flow-119.70
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM10.96
Price/Cash Flow Ratio66.6
Price/Free Cash Flow Ratio - LTM71.9
Price/Sales Ratio14.84
P/E Ratio (1 month ago) - LTM72.3
P/E Ratio (26 weeks ago) - LTM83.4
P/E Ratio (52 weeks ago) - LTM93.3
5-Y High P/E Ratio119.9
5-Y Low P/E Ratio9.4
5-Y Average P/E Ratio66.9
Current P/E Ratio as % of 5-Y Average P/E96
P/E as % of Industry Group241.0
P/E as % of Sector Segment48.0
Current 12 Month Normalized P/E Ratio - LTM55.1
PER SHARE FIGURES
LT Debt pS0.52
Current Liabilities pS1.85
Tangible Book Value pS - LTM0.00
Book Value pS - LTM12.00
Capital Invested pS10.57
Cash pS - LTM1.97
Cash Flow pS - LTM0.00
Free Cash Flow pS - LTM0.00
Earnings pS (EPS)1.78
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-19.13
Free Cash Flow Margin 5YEAR AVG8.28
Net Profit Margin22.5
Net Profit Margin - 5YEAR AVRG.18.0
Equity Productivity0.58
Return on Equity (ROE)12.9
Return on Equity (ROE) - 5YEAR AVRG.11.4
Capital Invested Productivity0.55
Return on Capital Invested (ROCI)12.3
Return on Capital Invested (ROCI) - 5YEAR AVRG.10.9
Assets Productivity0.60
Return on Assets (ROA)9.8
Return on Assets (ROA) - 5YEAR AVRG.8.9
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.91.0
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin35.1
Pre-Tax Profit Margin - 5YEAR AVRG.28.8
Effective Tax Rate35.9
Effective Tax Rate - 5YEAR AVRG.-31.1
EFFICIENCY RATIOS
Cash Conversion Cycle402
Revenue per Employee826,012
Net Income per Employee185,595
Average Collection Period94
Receivables Turnover4.2
Day's Inventory Turnover Ratio308
Inventory Turnover1.2
Inventory/Sales8.3
Accounts Payble/Sales9.64
Assets/Revenue1.67
Net Working Capital Turnover1.00
Fixed Assets Turnover1.01
Total Assets Turnover0.6
Revenue per $ Cash1.15
Revenue per $ Plant6.85
Revenue per $ Common Equity0.58
Revenue per $ Capital Invested0.55
Selling, General & Adm/tive (SG&A) as % of Revenue33.9
SG&A Expense as % of Revenue - 5YEAR AVRG.39.5
Research & Devlopment (R&D) as % of Revenue19.6
R&D Expense as % of Revenue - 5YEAR AVRG.19.6

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxn140416 12:12